Abstract
Intermediary metabolism in cancer cells is regulated by diverse cell-autonomous processes, including signal transduction and gene expression patterns, arising from specific oncogenotypes and cell lineages. Although it is well established that metabolic reprogramming is a hallmark of cancer, we lack a full view of the diversity of metabolic programs in cancer cells and an unbiased assessment of the associations between metabolic pathway preferences and other cell-autonomous processes. Here, we quantified metabolic features, mostly from the 13C enrichment of molecules from central carbon metabolism, in over 80 non-small cell lung cancer (NSCLC) cell lines cultured under identical conditions. Because these cell lines were extensively annotated for oncogenotype, gene expression, protein expression, and therapeutic sensitivity, the resulting database enables the user to uncover new relationships between metabolism and these orthogonal processes. Metabolic reprogramming influences therapeutic sensitivity in cancer, but the scope of metabolic diversity among cancer cells is unknown. Chen et al. characterized metabolic phenotypes in over 80 non-small cell lung cancer cell lines and then used genomics, transcriptomics, proteomics, and therapeutic sensitivities to uncover relationships between metabolism and orthogonal processes.
Original language | English (US) |
---|---|
Pages (from-to) | 838-851.e5 |
Journal | Molecular cell |
Volume | 76 |
Issue number | 5 |
DOIs | |
State | Published - Dec 5 2019 |
Keywords
- C stable isotope labeling
- cancer metabolism
- cell lines
- gene expression
- glucose
- glutamine
- non-small cell lung cancer
- oncogenotypes
- protein expression
- therapeutic sensitivity
ASJC Scopus subject areas
- Molecular Biology
- Cell Biology